Adam Koppel Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam Koppel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam Koppel. Adam Koppel is a EVP, Strategy and Bus. Dev. in BIOGEN INC. ($IDPH) and a SVP, Chief Strategy Officer in BIOGEN INC. ($IDPH) and a Director in PTC THERAPEUTICS, INC. ($PTCT) and a Director in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in TREVENA INC ($TRVN) and a Director in Aptinyx Inc. ($APTX) and a Director in Solid Biosciences Inc. ($SLDB) and a Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).
Address: C/O BROOKISDE CAPITAL MANAGEMENT, LLC JOHN HANCOCK TOWER, 200 CLARENDON ST. BOSTON 02116 MA
Companies in which Adam Koppel is an Insider
Aptinyx Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam Koppel: Director
Holdings: 5,558,425 shares
Latest Transaction: Jan 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOGEN INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Adam Koppel: EVP, Strategy and Bus. Dev., SVP, Chief Strategy Officer
Holdings: 2,402 shares
Latest Transaction: Jun 07 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cerevel Therapeutics Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam Koppel: Director
Holdings: 60,632,356 shares
Latest Transaction: Nov 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dicerna Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam Koppel: Director
Holdings: 3,080,237 shares
Current Value: $7,947,011
Latest Transaction: Dec 14 2020
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PTC THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam Koppel: Director
Holdings: 2,333,333 shares
Current Value: $31,406,662
Latest Transaction: Jan 05 2017
$PTCT Market Capitalization: $452.34M
$PTCT Previous Close: $13.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Solid Biosciences Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Adam Koppel: Director
Holdings: 7,060,353 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TREVENA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam Koppel: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 17 2018
$TRVN Market Capitalization: $406.64M
$TRVN Previous Close: $7.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Adam Koppel
Sentiment: All, APTX, IDPH, CERE, DRNA, PTCT, SLDB, TRVN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2021 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 3.46 | 5,508 | 19,058 | 5,508 | |
| Jan 05 2021 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 3.46 | 5,508 | 19,058 | 5,508 | |
| Dec 14 2020 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Sell | S | 23.40 | 1,000,000 | 23,400,000 | 3,080,237 | 4.1 M to 3.1 M (-24.51 %) |
| Dec 11 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Grant | A | 3.70 | 3,189,189 | 11,799,999 | 7,060,353 | 3.9 M to 7.1 M (+82.38 %) |
| Nov 12 2020 | ARYB | Cerevel Therapeuti ... | Koppel Adam | Director | Buy | P | 10.30 | 332,293 | 3,422,618 | 60,632,356 | 60.3 M to 60.6 M (+0.55 %) |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 3.03 | 10,000 | 30,300 | 10,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 |